Clinical Trial Update: Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a viral therapy for relapsed or refractory multiple myeloma has completed enrollment. The trial also included patients with light chai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Deposition Disease
• Multiple Myeloma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Light Chain Deposition Disease, Refractory Plasma Cell Myeloma | Phase 1 | Status: COMPLETED